IM

Insilico Medicine

Organization

Heard in 9 episodes across 4 shows since Aug 2026

A biotechnology company using artificial intelligence for drug discovery, target identification, molecular design, and aging-related research.

Learn more

Episodes

9
across 4 shows

First heard

Aug 2026

Expert statements

1
1 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20261
Sep 20268
Oct 20260

What experts have said about Insilico Medicine

1 statement · 1 positive

  1. Anthony StevensPositiveSep 30, 2026· Stock Movers

    Insilico shares rose about 8% after releasing an obesity-targeting molecule.

    “Insilico, which is an AI-driven drugs developer, that's up around 8% as it releases a molecule to perhaps tackle obesity”

    Listen at 1:11

    Open the episode · Insilico Rises, Hygon Dips, AOU Gains
Filter the statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

9 episodes featuring Insilico Medicine, newest first

See all 9 episodes →
Insilico Medicine · PodLume